Evidence map›Paper›PMID 41229991›Full record

ArticleJournal of extracellular biology2025

Enrichment of Immune Cell-Derived Extracellular Vesicles From Plasma Using 35 and 70 nm Size-Exclusion Chromatography Columns of Different Sizes.

Iris Potakowskyj, Ivan Bagarić, Nevena Prodanović, Adrián Parrilla Mesas, Olga Glatki, Klaus Heukamp, Kenneth W Witwer, Hanns-Martin Lorenz, Lars-Oliver Tykocinski, Aoife Ward Gahlawat and 1 more

Abstract read
In one paragraph

Article in Journal of extracellular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iris PotakowskyjBioMed X Institute Heidelberg Germany.
Ivan BagarićBioMed X Institute Heidelberg Germany.
Nevena ProdanovićDepartment of Radiation Oncology, Heidelberg Faculty of Medicine Heidelberg University Heidelberg Germany.
Adrián Parrilla MesasBioMed X Institute Heidelberg Germany.
Olga GlatkiBioMed X Institute Heidelberg Germany.
Klaus HeukampDivision of Rheumatology, Department of Medicine V, Heidelberg Faculty of Medicine Heidelberg University Heidelberg Germany.
Kenneth W WitwerDepartment of Molecular and Comparative Pathobiology Johns Hopkins University School of Medicine Baltimore USA.
Hanns-Martin LorenzDivision of Rheumatology, Department of Medicine V, Heidelberg Faculty of Medicine Heidelberg University Heidelberg Germany.
Lars-Oliver TykocinskiDivision of Rheumatology, Department of Medicine V, Heidelberg Faculty of Medicine Heidelberg University Heidelberg Germany.
Aoife Ward GahlawatDepartment of Radiation Oncology, Heidelberg Faculty of Medicine Heidelberg University Heidelberg Germany.
Gorjana RackovBioMed X Institute Heidelberg Germany.ORCID https://orcid.org/0000-0001-6561-6357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) from blood plasma are promising biomarkers, as they carry surface markers indicative of their cell of origin. Size-exclusion chromatography (SEC) is commonly employed for EV enrichment, but the choice of pore size and plasma volume can significantly impact the yield, purity, and composition of isolated EVs. In this study, we systematically compared Izon SEC columns with pore sizes of 35 and 70 nm, using either 500 µL plasma (qEVoriginal, "small" column) or 10 mL plasma (qEV10, "large" column). Due to limited material obtained from small columns, fractions had to be pooled for downstream analyses, precluding detailed characterization of individual fractions. In contrast, the larger columns provided sufficient material to analyse each fraction separately, across multiple platforms, including nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), single-EV flow cytometry, MACSPlex surface protein array, immunoblotting, and LC-MS/MS. These analyses consistently identified fractions 1-3 as "EV-rich," characterized by enrichment of EV markers and reduced levels of abundant plasma proteins. Moreover, a comparison of pore sizes demonstrated that the 70 nm column yielded a higher EV recovery with improved purity compared to the 35 nm column, including a greater abundance of immune cell-derived markers. Together, these findings established that the large 70 nm SEC columns are optimal for isolating EV-rich fractions from plasma, maximizing both EV yield and purity, while minimizing non-EV contaminants.

Identifiers

PMID41229991
PMCPMC12603795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.